Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alternative Treatment Paradigm for Natalizumab Trial

Trial Profile

Alternative Treatment Paradigm for Natalizumab Trial

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 09 May 2019

At a glance

  • Drugs Glatiramer acetate (Primary) ; Methylprednisolone (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ATP
  • Most Recent Events

    • 02 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
    • 26 Apr 2013 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 26 Apr 2013 Planned initiation date (Jul 2013) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top